As of May 17th 2020, the novel coronavirus disease 2019 (COVID-19) pandemic has
caused 307,395 deaths worldwide, out of 3,917,366 cases reported to the World Health …

More than seven months into the coronavirus disease-19 (COVID-19) pandemic, infection
from the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has led to over …

Patients with severe COVID-19 experience cytokine storm, an uncontrolled upregulation of
pro-inflammatory cytokines, which if unresolved leads to acute respiratory distress syndrome …

Mesenchymal stromal cells (MSCs) constitute a heterogeneous population of stromal cells
with immunomodulatory and regenerative properties that support their therapeutic use …

Abstract Coronavirus disease 2019 (COVID-19) is a highly infectious epidemic disease that
has seriously affected human health worldwide. To date, however, there is still no definitive …

Abstract The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread into more than 200 countries …

Abstract Background Mesenchymal stromal cells (MSCs) may reduce mortality in patients
with COVID-19; however, early evidence is based on few studies with marked interstudy …

Background The present study aims to better understand the efficacy and safety of
mesenchymal stromal cells (MSCs) in treating severe/critical patients with COVID-19 …

Background Mesenchymal stem/stromal cells (MSCs) and their secreted products are a
promising therapy for COVID-19 given their immunomodulatory and tissue repair …

The severe respiratory consequences of the coronavirus disease 2019 (COVID-19)
pandemic have prompted the urgent need for novel therapies. Cell-based therapies …